LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling

Author:

Ye Yanle1ORCID,Zhang Feng2,Chen Qingxia3,Huang Zhiyang1,Li Meijun4

Affiliation:

1. Department of Urology; The First Hospital of Quanzhou Affiliated of Fujian Medical University; Quanzhou, Fujian Province China

2. Department of Urology; ShangHai Eighth People's Hospital; Shanghai China

3. Department of Anesthesiology; The First Hospital of Quanzhou Affiliated of Fujian Medical University; Quanzhou, Fujian Province China

4. Department of Nursing; Quanzhou Medical College; Quanzhou, Fujian Province China

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Reference47 articles.

1. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J Clin,2016

2. Studying cancer families to identify kidney cancer genes;Zbar;Ann Rev Med,2003

3. Cancer statistics. 2014;Siegel;CA Cancer J Clin,2014

4. VHL and HIF-1alpha: gene variations and prognosis in early-stage clear cell renal cell carcinoma;Lessi;Med Oncol,2014

5. Systemic therapy in renal cell carcinoma: advancing paradigms;Posadas;Oncology,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3